https://www.pharmaceutical-technology.com/news/vbi-hepatitis-b-partnership/
VBI Vaccines has announced the expansion of its HBV partnership with Brii Bio to address prevention and treatment of the disease.
vbi vaccinesbriibiosciencesexpandhepatitis
https://www.globenewswire.com/fr/news-release/2019/08/05/1896803/0/en/VBI-Vaccines-to-Present-at-the-Canaccord-Genuity-39th-Annual-Growth-Conference.html
CAMBRIDGE, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (
vbi vaccinescanaccord genuitypresent
https://www.pharmaceutical-technology.com/comment/vbi-vaccines-pursues-future-hepatitis-b-vaccine-showdown-dynavax/
This past December, VBI Vaccines announced it had initiated two parallel Phase III trials of their hepatitis B vaccine, Sci-B-Vac (hepatitis B [virus-like...
hepatitis b vaccinevbi vaccinesfutureshowdown
https://www.globenewswire.com/fr/news-release/2019/06/20/1871803/0/en/VBI-Vaccines-to-Present-at-the-BMO-Capital-Markets-2019-Prescriptions-for-Success-Healthcare-Conference.html
CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (
bmo capital marketsvbi vaccinespresent